ALNA Allena Pharmaceuticals NASDAQ Feb 2026 close $0.075, 252M vol: what’s next
ALNA stock closed $0.075 on Feb 2026 with 252.31M shares. We analyze catalysts, valuation, and a Meyka AI forecast for investors
ALNA stock closed $0.075 on Feb 2026 with 252.31M shares. We analyze catalysts, valuation, and a Meyka AI forecast for investors
RBC keeps Outperform on Ferguson plc; price target raised to $271. FERG analyst rating update and implications
STETHUSD technical analysis shows oversold conditions with RSI at 29.75. Explore price levels, forecasts, and what’s driving Lido Staked ETH today.
Jefferies maintains Buy and lifts price target, a timely HD analyst rating update
Pre-market: VAGHANI.BO stock rises to INR 284.25 on high volume; technicals overbought and Meyka AI forecasts show model downside.
ALNEV.PA stock: Neovacs closed at €0.0018 on EURONEXT with 14.53M shares and high short-term volatility
Rob Reiner case puts entertainment insurance costs and production delay risk in focus for Australian investors. We explain how insurers, producers, and streamers may react, what Nick Reiner’s arraign
SKIN.SW stock jumps 9.85% on high volume to CHF35.70 on SIX — short-term outlook and Meyka AI forecast
BAYN.DE stock jumps to €45.58 on high volume; Meyka AI forecasts €49.38 monthly target for BAYN.DE stock
Novo Nordisk stock today plunged up to 17% after CagriSema lagged Eli Lilly’s tirzepatide, rattling OMX Copenhagen 25 and the krone. What this means for German investors, risks, and next catalysts.